Metraipolis › archive › dc_1fec588b99ee

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40883741
DOI
10.1186/s13046-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-10T06:40:30.929Z
SHA-256 of the archived text
916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48
Stable URL of this page
https://metraipolis.com/documento/dc_1fec588b99ee

How to cite

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741 — Europe PMC (en), https://europepmc.org/article/MED/40883741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fec588b99ee (Metraipolis archive dc_1fec588b99ee, sha256 916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48)
BibTeX
@misc{dc1fec588b99ee,
  title = {Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation — Europe PMC PMID:40883741},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40883741},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fec588b99ee; sha256 916292de62320b258bc16b66025f25df51c6285edb2a68faa076a626aeb02d48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40883741. Agents can read the archived copy with the MCP tool read_document.